Related Experiment Video
Updated: Aug 7, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
[Pediatric neuro-oncology]
1Departmento de Pediatría, Universidad del País Vasco, Unidad de Oncología Pediátrica, Hospital de Cruces, Barakaldo, Vizcaya, Espana.
Insights
Pediatric brain tumors are common and require early diagnosis and tailored treatments. Advances in neuro-imaging and genetic profiling improve survival rates for children with brain tumors.
Area of Science:
- Pediatric neuro-oncology
- Childhood brain tumor research
Context:
- Brain tumors are the most common solid tumors in children under 15.
- Advances in neuro-imaging enable earlier diagnosis.
- Pediatric oncology units utilize internationally based treatment protocols.
Purpose:
- Review unique characteristics of pediatric brain tumors compared to adult tumors.
- Provide incidence and survival data for pediatric brain tumors in Spain.
- Outline diagnostic strategies, imaging modalities, and treatment protocols stratified by risk markers.
Summary:
- Classification of brain tumors now includes biological, genetic, and molecular risk factors.
- Treatment must consider familial predisposition and tumor molecular markers.
- Focus on common pediatric brain tumor subtypes: gliomas, medulloblastomas/primitive neuroectodermal tumors, and ependymomas.
Impact:
- Early detection through imaging and biological techniques improves prognosis.
- Multicenter protocols in specialized units enhance treatment efficacy.
- Stratified treatments based on biological risk reduce morbidity and long-term effects.
Introduction:
Pediatric neuro-oncology is getting more important for various reasons, brain tumours are the most frequent solid tumours in children below fifteen year of age, besides due to the recent advances in neuro-image techniques that make possible an early diagnosis and the fact that the children are usually treated in pediatric oncology units, with protocols that are internationally based allow a better survival with a better degree of evidence.
Development:
Actually the brain tumours should be classified according to their biological, genetic and molecular risk factors and their treatment should consider also the familial predisposition for developing a brain tumour, and the molecular markers expressed by the tumour. The objective of this work is to review the special characteristics of the brain tumours in the pediatric population and the differences with the brain tumours in adults, also to give the incidence and survival data of brain tumours in pediatric population from Spain based in the data from the National Registry of Pediatric Tumours. Also the clinical signs and symptoms of presentation that should alert for diagnosis in children, and how to make a diagnostic strategy based on the clinical manifestations, the image modalities for diagnosis, and the treatment strategy to be used based in multinational protocols, and stratified by histological, biological and genetic markers of risk are emphasized. Finally we describe the characteristics of the three more common histological subtypes because their prevalence in pediatric population; gliomas, medulloblastomas/primitive neuroectodermal tumours and ependymomas.
Conclusion:
Improving prognosis of brain tumors in childhood has to be achieved by early despistage throughout image and biological techniques, following multicentric protocols in specialized units and stratified treatments regarding the biological risk in order to diminish morbility and sequels.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
